Humoral memory, a key feature of adaptive immunity, is vital for vaccine protection against microbes but may also foster persistence of some auto-immune diseases. Long-lived plasma cells constitutively secrete epitope-specific antibody (Ab) after a first encounter with antigen (Ag), but after longer periods this population can need replenishment that is achieved by re-activation of Ag-specific memory B (Bmem) cells. T cell help and the germinal center (GC) reaction foster IgM+ and class-switched Bmem cells, and promote recall responses with high-affinity Ab. Among the potential fates of a B cell after its activation, remarkably little is known about how signaling within B cells regulates the formation, persistence, or reactivation of memory. In T cells, accumulating evidence suggests an interplay of cell metabolism with signaling and their functions and fates. The distinct biology of B cells an memory suggests that Bmem may use mechanisms different from T cells, yet very little is known about B lineage memory regulation. Target of Rapamycin (TOR), a major nexus for regulation of energy use in biosynthesis, is a serine-threonine kinase inhibited by the immune modulatory drug rapamycin. The goal of this research is to elucidate how mTOR regulates lymphocyte functions. TOR kinase participates in two functionally distinct adapter complexes, so that its enzymatic activity is acutely impaired in mTORC1 whereas the impact of allosteric inhibitors (e.g., rapamycin) on mTORC2 is time- and cell type-dependent. In an apparent paradox, rapamycin may block B cell proliferation and the generation of class-switched Ab, and yet re-vaccination responses in rapamycin-treated patients appear grossly intact. We have found that B lineage cells require expression of Rictor, a core component of mTOR complex 2 in B cells, to maintain the capacity for a recall Ab response. These and further findings lead us to hypothesize that Rictor, in part because it scaffolds mTORC2, promotes the generation or maintenance of Ag-specific memory B cells, and that this function is exerted at least in part through inhibition of FoxO1. To test the impact of mTOR on humoral memory, we have three specific Aims. The first is to elucidate the stages at which Rictor promotes protective Ab and humoral memory via T and B lineages (AIM 1). We also aim to determine B lineage-intrinsic molecular mechanisms whereby Rictor acts in B lineage recall (AIM 2). In parallel, we will use genetic approaches to determine what is the impact of mTORC1 on primary and recall Ab responses (AIM 3). We will identify mechanisms by which mTORC1 regulates the spectrum of Ig classes in immunity, and test a model that AID expression is enhanced by but not absolutely dependent on mTORC1, and is relatively rapamycin-resistant in Bmem cells. The expected outcome of the studies is that we will uncover novel but divergent roles for mTORC1 and 2 in determining the functional outcomes for B lineage cells and humoral immunity. In particular, we expect to find that mTOR acts to promote Bmem cells by mTORC1 & 2-dependent mechanisms, and that mTORC1 regulates not only B cell proliferation and clonal expansion, but the spectrum of switched Ig classes after immunization.

Public Health Relevance

The ability to maintain or renew high enough concentrations of antibodies protects us against disease caused by various microbes and is central to vaccine efficacy, yet also can be part of how various immune-mediated diseases such as lupus undermine our health. These long-lived antibody responses are produced after one class of white blood cells is activated, interacts with other classes of cell, differentiates to new fates, nd persists for years. This proposal seeks support to allow us to identify important signaling mechanisms that regulate how one immunosuppressive drug alters antibody responses, and how long-term memory is formed and maintained for B lineage cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL106812-05A1
Application #
8886296
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Kindzelski, Andrei L
Project Start
2011-01-15
Project End
2019-03-31
Budget Start
2015-04-02
Budget End
2016-03-31
Support Year
5
Fiscal Year
2015
Total Cost
$392,466
Indirect Cost
$142,466
Name
Vanderbilt University Medical Center
Department
Pathology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Raybuck, Ariel L; Cho, Sung Hoon; Li, Jingxin et al. (2018) B Cell-Intrinsic mTORC1 Promotes Germinal Center-Defining Transcription Factor Gene Expression, Somatic Hypermutation, and Memory B Cell Generation in Humoral Immunity. J Immunol 200:2627-2639
Boothby, Mark; Rickert, Robert C (2017) Metabolic Regulation of the Immune Humoral Response. Immunity 46:743-755
Sai, Jiqing; Owens, Philip; Novitskiy, Sergey V et al. (2017) PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses. Clin Cancer Res 23:3371-3384
Cho, Sung Hoon; Raybuck, Ariel L; Stengel, Kristy et al. (2016) Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system. Nature 537:234-238
Wang, Shan; Amato, Katherine R; Song, Wenqiang et al. (2015) Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways. Mol Cell Biol 35:1299-313
McGuire, Victoria A; Gray, Alexander; Monk, Claire E et al. (2013) Cross talk between the Akt and p38? pathways in macrophages downstream of Toll-like receptor signaling. Mol Cell Biol 33:4152-65
Rosborough, Brian R; Raïch-Regué, Dàlia; Matta, Benjamin M et al. (2013) Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction. Blood 121:3619-30
Cho, Sung Hoon; Raybuck, Ariel; Wei, Mei et al. (2013) B cell-intrinsic and -extrinsic regulation of antibody responses by PARP14, an intracellular (ADP-ribosyl)transferase. J Immunol 191:3169-78
Lee, Keunwook; Boyd, Kelli L; Parekh, Diptiben V et al. (2013) Cdc42 promotes host defenses against fatal infection. Infect Immun 81:2714-23
Volanakis, Emmanuel J; Boothby, Mark R; Sherr, Charles J (2013) Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia. Exp Hematol 41:377-86

Showing the most recent 10 out of 17 publications